These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 1323104)

  • 61. Bone marrow findings of 23 Korean post-transplant lymphoproliferative disorder patients: a single-center experience.
    Cho MC; Park CJ; Huh J; Chi HS; Jang S; Suh C; Lee KH; Lee JH; Seo JJ; Im HJ
    Clin Transplant; 2012; 26(4):E381-7. PubMed ID: 22694766
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Demonstration of Epstein-Barr viral DNA in paraffin-embedded specimens of lymphoproliferative syndrome. Evidence for a productive infection comparable to lymphoblastoid cell lines.
    Simon M; Neumann R; Bültmann B
    Pathol Res Pract; 1992 Feb; 188(1-2):106-14. PubMed ID: 1317554
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation.
    Montone KT; Litzky LA; Wurster A; Kaiser L; Bavaria J; Kotloff R; Palevsky H; Pietra GG; Tomaszewski JE
    Surgery; 1996 May; 119(5):544-51. PubMed ID: 8619211
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epstein-Barr virus infection-associated renal disease: diagnostic use of molecular hybridization technology in patients with negative serology.
    Nadasdy T; Park CS; Peiper SC; Wenzl JE; Oates J; Silva FG
    J Am Soc Nephrol; 1992 Jun; 2(12):1734-42. PubMed ID: 1323338
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Primary cutaneous giant cell plasmacytoma in an organ transplant recipient: a rare presentation of a posttransplant lymphoproliferative disorder.
    Wang E; Stoecker M
    Am J Dermatopathol; 2010 Jul; 32(5):479-85. PubMed ID: 20414094
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Circulating Epstein-Barr virus DNA to monitor lymphoproliferative disease following pediatric liver transplantation.
    Gridelli B; Spada M; Riva S; Colledan M; Segalin A; Lucianetti A; Sonzogni A; Furione M; Baldanti F; Torre G
    Transpl Int; 2000; 13 Suppl 1():S399-401. PubMed ID: 11112041
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Detection of Epstein-Barr virus in cardiac biopsies of heart transplant patients with lymphoproliferative disorders.
    Hanasono MM; Kamel OW; Chang PP; Rizeq MN; Billingham ME; van de Rijn M
    Transplantation; 1995 Sep; 60(5):471-3. PubMed ID: 7676496
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders.
    Dharnidharka VR; Ruzinova MB; Chen CC; Parameswaran P; O'Gorman H; Goss CW; Gu H; Storch GA; Wylie K
    Cancer Med; 2019 Mar; 8(3):1013-1023. PubMed ID: 30697958
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
    Ferguson NN; Thomas CP; Hohl RJ; Syrbu SI; Stone MS; Wanat KA
    Am J Dermatopathol; 2015 Oct; 37(10):790-4. PubMed ID: 25747810
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of p16/INK4a in posttransplantation lymphoproliferative disorders.
    Martin A; Baran-Marzak F; El Mansouri S; Legendre C; Leblond V; Charlotte F; Davi F; Canioni D; Raphaël M
    Am J Pathol; 2000 May; 156(5):1573-9. PubMed ID: 10793069
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CD30 expression and survival in posttransplant lymphoproliferative disorders.
    Kinch A; Amini RM; Hollander P; Molin D; Sundström C; Enblad G
    Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
    [No Abstract]   [Full Text] [Related]  

  • 72. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
    Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Posttransplant lymphoproliferative disorder in pediatric patients.
    Hussein K; Tiede C; Maecker-Kolhoff B; Kreipe H
    Pathobiology; 2013; 80(6):289-96. PubMed ID: 24013821
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of Epstein-Barr virus load in saliva before and after renal transplantation.
    Nikoobakht M; Beitollahi J; Nikoobakht N; Aloosh M; Sahebjamee M; Rezaeidanesh M; Biniaz F
    Transplant Proc; 2011 Mar; 43(2):540-2. PubMed ID: 21440755
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens.
    Meru N; Davison S; Whitehead L; Jung A; Mutimer D; Rooney N; Kelly D; Niedobitek G
    Mol Pathol; 2001 Aug; 54(4):264-9. PubMed ID: 11477143
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma.
    Timms JM; Bell A; Flavell JR; Murray PG; Rickinson AB; Traverse-Glehen A; Berger F; Delecluse HJ
    Lancet; 2003 Jan; 361(9353):217-23. PubMed ID: 12547545
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evidence of Epstein-Barr virus heterogeneous gene expression in adult lung transplant recipients with posttransplant lymphoproliferative disorder.
    Zaffiri L; Frankel C; Bush EJ; Neely ML; Pavlisko EN; Mokrova IL; Luftig MA; Palmer SM
    J Med Virol; 2021 Aug; 93(8):5040-5047. PubMed ID: 33704812
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
    Preiksaitis JK; Diaz-Mitoma F; Mirzayans F; Roberts S; Tyrrell DL
    J Infect Dis; 1992 Nov; 166(5):986-94. PubMed ID: 1328412
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Kidney allograft with a lymphocytic infiltrate: acute rejection, posttransplantation lymphoproliferative disorder, neither, or both entities?
    Trpkov K; Marcussen N; Rayner D; Lam G; Solez K
    Am J Kidney Dis; 1997 Sep; 30(3):449-54. PubMed ID: 9292579
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease.
    Savoie A; Perpête C; Carpentier L; Joncas J; Alfieri C
    Blood; 1994 May; 83(9):2715-22. PubMed ID: 8167350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.